Shares of Core Laboratories NV (NYSE:CLB) gapped down before the market opened on Monday . The stock had previously closed at $111.04, but opened at $111.43. Core Laboratories NV shares last traded at $112.32, with a volume of 295,200 shares trading hands.

Several analysts have recently weighed in on CLB shares. Zacks Investment Research raised shares of Core Laboratories NV from a “hold” rating to a “buy” rating and set a $138.00 price target for the company in a research note on Wednesday, July 20th. JPMorgan Chase & Co. reaffirmed a “buy” rating on shares of Core Laboratories NV in a research note on Thursday, June 30th. KLR Group reaffirmed a “buy” rating and set a $180.00 price target (up previously from $166.00) on shares of Core Laboratories NV in a research note on Monday, June 13th. Credit Suisse Group AG started coverage on shares of Core Laboratories NV in a research note on Thursday. They set a “neutral” rating and a $115.00 price target for the company. Finally, Citigroup Inc. decreased their price target on shares of Core Laboratories NV from $123.00 to $118.00 and set a “neutral” rating for the company in a research note on Monday, July 25th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and seven have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $121.29.

The company has a market capitalization of $4.95 billion and a price-to-earnings ratio of 59.59. The company has a 50 day moving average of $117.13 and a 200-day moving average of $117.60.

Core Laboratories NV (NYSE:CLB) last issued its quarterly earnings data on Wednesday, July 20th. The company reported $0.35 EPS for the quarter, hitting the consensus estimate of $0.35. During the same quarter in the prior year, the company posted $0.81 earnings per share. The company earned $148.10 million during the quarter, compared to analyst estimates of $146.37 million. The business’s revenue was down 27.4% compared to the same quarter last year. Analysts predict that Core Laboratories NV will post $1.57 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 15th. Stockholders of record on Monday, July 18th were issued a $0.55 dividend. The ex-dividend date was Thursday, July 14th. This represents a $2.20 annualized dividend and a dividend yield of 1.96%.

Core Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company’s services and products are directed toward enabling the Company’s clients to improve reservoir performance and increase oil and gas recovery from their producing fields.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.